Press release
Investigation announced for NASDAQ: ZY Investors over possible Wrongdoing at Zymergen Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Zymergen Inc..Investors who are current long term investors in Zymergen Inc. (NASDAQ: ZY) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ZY stocks follows a lawsuit filed against Zymergen Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ZY stocks, concerns whether certain Zymergen directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants failed to disclose to investors that, during the qualification process for Hyaline, key customers had encountered technical issues, including product shrinkage and incompatibility with customers’ processes, that, though the qualification process was critical to achieving market acceptance for Hyaline and generating revenue, Zymergen lacked visibility into the qualification process, that, as a result, the Company overestimated demand for its products, that, as a result of the foregoing, the Company’s product delivery timeline was reasonably likely to be delayed, which in turn would delay revenue generation, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Zymergen Inc. (NASDAQ: ZY) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for NASDAQ: ZY Investors over possible Wrongdoing at Zymergen Inc. here
News-ID: 2441041 • Views: …
More Releases from Shareholders Foundation
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
More Releases for Zymergen
Engineered Bacterial Cell Protein Market Is Going to Boom |• Ginkgo Bioworks …
Worldwide Market Reports has released a new in-depth research study on the "Engineered Bacterial Cell Protein Market," highlighting strong growth potential in the coming years. The report delivers a structured and data-driven analysis of the market landscape, combining robust research methodology, market sizing, validated data modeling, and insights sourced from reliable primary and secondary channels.
The study thoroughly examines key market aspects, including growth drivers, restraints, challenges, emerging opportunities, technological advancements,…
Synthetic Biology Market Hits New High | Major Giants Ginkgo Bioworks, Amyris, Z …
HTF MI just released the Global Synthetic Biology Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Synthetic Biology Market are: Ginkgo Bioworks, Amyris,…
Nanobots Market Growth | Trends, Size & Forecast 2024-2031 | Xidex Corp., Zymerg …
The Nanobots Market is expected to grow at a CAGR of 10.8% during the forecasting period 2024-2031.
Nanobots Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that…
Healthcare Bioconvergence Market May See Big Move | Zymergen, BiomX, Singota Sol …
Archive Market Research published a new research publication on "Healthcare Bioconvergence Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Healthcare Bioconvergence market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Computational Toxicology Software Market Show Incredible Growth Soon | Certara, …
According to HTF Market Intelligence, the Global Computational Toxicology Software market to witness growth a CAGR of 11.7% during forecast period of 2024-2030. The Global Computational Toxicology Software Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing.
Key Players in This Report Include:
Accelrys…
Lawsuit filed for Investors in shares of Zymergen Inc. (NASDAQ: ZY)
An investor, who purchased shares of Zymergen Inc. (NASDAQ: ZY), filed a lawsuit over alleged violations of Federal Securities Laws by Zymergen Inc. in connection with the Company’s April 2021 initial public offering (“IPO” or the “Offering”).
Investors who purchased shares of Zymergen Inc. (NASDAQ: ZY) have certain options and for certain investors are short and strict deadlines running. Deadline: October 04, 2021. NASDAQ: ZY investors should contact the Shareholders Foundation…
